Research and Markets: Ophthalmology - Allergan / Pharmacopeia Tie-up Unlikely to See Much Success...DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c23067) has announced the addition of MarketWatch: Insight into Key Events in Healthcare Industry to their offering. The MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the months major issues and events in R&D, regulatory and licensing in the Healthcare industry. In this month's MarketWatch... --Pharmaceutical Company Round-up --Cancer Update --News Round-up --Opinion: Bayer/Onyx: sorafenib could raise bar in kidney cancer Kidney Cancer Definition Kidney cancer is a disease in which the cells in certain tissues of the kidney start to grow uncontrollably and form tumors. ... --Opinion: AstraZeneca: Iressa loses battle with Tarceva... --Opinion: OSI (1) (Open System Interconnection) An ISO standard for worldwide communications that defines a framework for implementing protocols in seven layers. Control is passed from one layer to the next, starting at the application layer in one station, proceeding to the / Roche / Genentech: European approval would confirm Tarcevas lead... --Opinion: AstraZeneca: Zactima could help regain lost ground... --Feature Analysis: Cancer therapy: clinical trials to trigger antihormonals market shift... --Cardiovascular Update --News Round-up --Opinion: Kos Pharmaceuticals: Niaspan combination could offer another string to its cardio bow... --Opinion: Ophthalmology: Allergan / Pharmacopeia pharmacopeia /phar·ma·co·pe·ia/ (-ko-pe´ah) an authoritative treatise on drugs and their preparations. See also USP. pharmacopei´al United States Pharmacopeia see under U. tie-up unlikely to see much success... --Feature Analysis: Is diagnosis failing heart failure patients? --CNS Update --News Round-up --Opinion: Drug safety: walking the marketing tightrope... --Opinion: Johnson & Johnson: Concerta label change likely but generics pose greater threat... --Opinion: NeurogesX: easing pain for revenue gain... --Opinion: Novartis / Procter & Gamble: Enablex going global... --Opinion: Roche/GSK: injection matches pills in osteoporosis ills... --IDI Update --News Round-up --Opinion: Psoriatic and rheumatoid arthritis rheumatoid arthritis Chronic, progressive autoimmune disease causing connective-tissue inflammation, mostly in synovial joints. It can occur at any age, is more common in women, and has an unpredictable course. : Humira extension would be a boon for Abbott... --Opinion: Pfizer/Sanofi-Aventis: Exubera exudes optimism... --Feature Analysis: Daxas deal leaves Altana short of breath... --Infectious Diseases Update --News Round-up --Opinion: Sanofi-Aventis: Adacel can address adult whooping cough whooping cough or pertussis, highly communicable infectious disease caused by the bacterium Bordetella pertussis. The early or catarrhal stage of whooping cough is manifested by the usual symptoms of an upper respiratory infection with --Opinion: Cubist: Cubicins success may not be enough to boost uptake... --Feature Analysis: Brazilian patent threat poses challenge to big pharma... --Feature Analysis: Novartis compound paves way for potent COPD COPD chronic obstructive pulmonary disease. COPD abbr. chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD) combinations... --Feature Analysis: Chronic viral hepatitis viral hepatitis n. Any of various forms of hepatitis caused by a virus. viral hepatitis, n an inflammatory condition of the liver, caused by the hepatitis viruses: A, B, C, delta, E, F, G, or H. : B is for billions... --Feature Analysis: Capravirine discontinued, but Pfizers HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. R&D wont stop... --Feature Analysis: Hepatitis C Hepatitis C Definition Hepatitis C is a form of liver inflammation that causes primarily a long-lasting (chronic) disease. Acute (newly developed) hepatitis C is rarely observed as the early disease is generally quite mild. : hope on the distant horizon... --Industry Features --Novartis: generic dominance may take Eons to realize... --Merck KGaA/Integra: landmark ruling could boost drug... --iSoft: Torex takeover is a shot in the arm... --Pfizer: bailing out of German generics... --Company Spotlight: Roche Holding AG --Biotechnology Update --Biotech News Round-up --Company Spotlight: Genentech, Inc. For more information visit http://www.researchandmarkets.com/reports/c23067. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion